Chen Xia has absolute confidence in saying this. After the invention of proton pump inhibitors, only 6 drugs will be released even in 2020.

They are omeprazole, lansoprazole, pantoprazole, rabeprazole, esomeprazole, and esuprazole.

In the decades later, everyone knew that the proton pump inhibitor was a hen that lays golden eggs. Would those international pharmaceutical companies want to get a share of the pie?

It’s not that I don’t want to, it’s really impossible.

There must be many related drug research, but there will be only 6 types that can be put on the market and entered the clinical stage in 40 years.

Now all the patents of these six proton pump inhibitor drugs are in Chen Xia's hands, or he is in the process where he can apply for patents at any time. He does not believe that other pharmaceutical companies can develop new products.

So who would like to forcefully copy omeprazole without regard to omeprazole's patent and put it into production and sales?

One day, Chen Xia didn't mind authorizing the upgraded version of the drug to other pharmaceutical companies for free and asking them to bite the dog.

Anyway, he has no losses and has not much research and development costs. He has enough drugs in the space hospital, so he is not bad for this type of drug.

So if you do such things that harm others and do not benefit yourself, there is no psychological pressure.

After hearing Chen Xia's "tlemn" advice, Marcia, the representative of Melko Huiduan Pharmaceutical, Chris Grelin, the manager of GlaxoSchiko Company, and Taro Kono, the representative of Takeda Pharmaceutical in Japan, look at me, and I look at you, and my eyes are helpless.

Chen Xia's advice hit them seven inches.

They can do this by forcibly imitating other people's patented drugs through a huge legal team and through various legal loopholes, they can fight a lasting lawsuit and drag down the plaintiffs.

In the face of absolute interests, how much money is the face of a company and an individual worth?

But they also need to pay a lot of lawyer fees and litigation fees. If they encounter a neurotic judge or senior officials of both countries intervene, the lawsuit may not be won.

The judicial cost is quite high. Don’t forget that lawyers in European and American countries can suck blood, especially barristers, who are billed according to "divisions".

Even if they finally dragged the plaintiff down, the laboratory would have to conduct a large number of phase 4 clinical trials, which would have to pass the FDA clinical trials, which would be very expensive.

Next, we will build new factories and production lines, hire a large number of workers, purchase a large amount of raw materials, and calculate the various upper-level public relations expenses, which are definitely not a small amount, at least more than a few hundred million US dollars.

But with so much investment, it is entirely possible that Chen Xia could have authorized them to their competitors for free to launch an upgraded version of the medicine to crush them with efficacy and price.

That's a big deal, the Chinese people have turned over the table.

At that time, not only will all investments be wasted, but the specific managers will definitely be held accountable by the board of directors. It is impossible to survive in this industry in the future.

Therefore, the path of bypassing patents and generic drugs is not feasible.

The representatives of the three pharmaceutical companies are not ordinary people. After thinking about this, they immediately changed the negotiation strategy.

Macia’s question, “Ms. Chen, Mr. Chen, I guess you have your favorite way of cooperation. You can raise it now. Although our authority is not enough, you can report to the board of directors immediately when you go back.”

Chris Grelin also smiled and said, "We are all friends of Professor Gregory, everything is easy to discuss."

Chen Shuqin and Chen Xia looked at each other and felt that the time was almost right, so we could talk about the conditions.

Chen Xia took the initiative to speak: "This is what we think. We don't sell drug patents, but we can use patent authorization."

Several representatives of pharmaceutical companies nodded. This is also an internationally accepted rule of the game and they can accept it.

"As for how to charge this patent fee, we have two methods. One is that we have to charge $2 for each pill, and the other is that we only charge 5% of the sales as the patent fee."

When Chris Grelin heard this number, he immediately exclaimed: "This is impossible, the cost is too high. If a pill charges only 2 cents, you can consider it."

Marcia and Taro Kono also shook their heads: "This number is too exaggerated. We have no profit at all, but it may be a loss."

Chen Xia disagreed: "Gentlemen, ladies, but you forgot one thing: our drug is in a monopoly position and has no other competitors. As long as we authorize your patents, you will have the right to price."

Pricing rights?

The three medical representatives immediately reacted, yes, it would be different with pricing power.

When any new drug is launched, it has a definite clinical effect and has no competitors, the price is often very, very high.

Just like the few drugs for treating cancer, they can be used to make money by using monopoly.

Now if Pumpkin Vine licenses the patent to them, they will save the research and clinical experiment costs that account for the largest cost. How much does it cost to produce drugs purely?

Taro Kono asked another key question:

"If you authorize patents and are preparing to grant several pharmaceutical companies? If you authorize them at will and have too many competitors, then pricing power will not be possible."

At this time, Chen Shuqin interrupted:

"We only authorize three companies, one in the Americas, one in Europe and Africa, one in Asia and one in Oceania. Of course, in Asia, we will exclude the Chinese and Xiangjiang markets, and we will do this market ourselves."

Taro Kono's eyes lit up when he heard this. If they take over Asia and Oceania, this will be a huge market with a population of more than 2 billion, and the sales will be absolutely considerable.

As for the Chinese market, how many people can afford medicines in such a poor country? They give up and give up.

This is also the common idea among the representatives of the three pharmaceutical companies. Of course, they will regret it in the future because they also missed a huge market with a population of more than one billion.

Chen Xia's purpose of doing this is also very clear. He wants to make money, but while making money, he also wants to make certain contributions to the medical market in China.

If the Chinese market gives in, the price of imported drugs is not accepted by Chinese people. So he wants to make this market by himself, and the price of drugs can be set a little lower, at least to make every Chinese person affordable to take medicine.

In a market with a population of more than one billion, only he provides these drugs, which is actually enough for him to make a fortune.

"So gentlemen and ladies, our conditions will not change, which is actually our biggest concession. Otherwise, we will build our own pharmaceutical factory and produce and sell our own, and will the profit be higher? Right?

You can report it yourself when you go back. If you three companies do not agree, I think there will always be so many pharmaceutical companies around the world that they agree. You will not have the chance to participate again. Now you will give the initiative to you first."
Chapter completed!